US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 47.930
  • -2.000-4.01%
Close Apr 25 16:00 ET
  • 50.060
  • +2.130+4.44%
Pre 07:19 ET
5.78BMarket Cap-10770P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
13.31%75.42M
-62.41%22.66M
290.37%22.06M
2,519.90%16.32M
14.38M
Operating revenue
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
13.31%75.42M
-62.41%22.66M
290.37%22.06M
2,519.90%16.32M
--14.38M
Cost of revenue
938.15%58.51M
580.75%19.91M
1,522.74%22.41M
10,118.29%8.38M
526.22%7.81M
8.38%5.64M
-42.09%2.93M
826.85%1.38M
82K
1.25M
Gross profit
384.45%338.08M
540.72%126.47M
325.58%87.99M
433.19%86.59M
181.99%37.04M
13.73%69.79M
-64.27%19.74M
275.84%20.68M
2,506.74%16.24M
13.13M
Operating expense
28.72%855.2M
14.80%210.98M
29.64%225.07M
25.58%207.03M
49.24%212.12M
11.17%664.4M
27.07%183.79M
30.05%173.61M
-15.42%164.86M
14.08%142.13M
Selling and administrative expenses
80.69%500.82M
67.96%141.7M
85.76%145.65M
76.21%111.37M
99.45%102.09M
56.79%277.16M
103.48%84.37M
71.33%78.41M
29.07%63.2M
26.14%51.19M
-General and administrative expense
80.69%500.82M
67.96%141.7M
85.76%145.65M
76.21%111.37M
99.45%102.09M
56.79%277.16M
103.48%84.37M
71.33%78.41M
29.07%63.2M
26.14%51.19M
Research and development costs
-8.48%354.39M
-30.32%69.28M
-16.58%79.42M
-5.90%95.66M
20.98%110.03M
-7.99%387.24M
-3.64%99.42M
8.52%95.21M
-30.34%101.66M
8.25%90.95M
Operating profit
13.03%-517.12M
48.48%-84.52M
10.37%-137.08M
18.96%-120.44M
-35.73%-175.08M
-10.88%-594.61M
-83.50%-164.05M
-19.49%-152.94M
23.50%-148.62M
-3.54%-129M
Net non-operating interest income expense
63.53%-8.65M
9.77%-2.85M
54.44%-2.32M
80.92%-1.34M
74.69%-2.14M
-84.92%-23.71M
-6.11%-3.16M
-138.26%-5.09M
-91.54%-7.02M
-108.86%-8.44M
Non-operating interest income
134.83%20.93M
-0.59%4.55M
77.61%4.99M
319.13%6M
5,403.06%5.39M
2,032.54%8.91M
12,264.86%4.58M
1,850.69%2.81M
1,276.92%1.43M
-26.87%98K
Non-operating interest expense
-9.33%29.58M
-4.34%7.4M
-7.50%7.31M
-13.10%7.34M
-11.82%7.53M
146.40%32.63M
156.39%7.74M
246.32%7.9M
124.26%8.45M
104.50%8.54M
Other net income (expense)
97.81%-727K
189.02%219K
98.16%-603K
-142.28%-63K
4.15%-277K
83.15%-33.18M
99.55%-246K
49.89%-32.79M
100.70%149K
99.47%-289K
Special income (charges)
--0
--0
--0
----
----
67.30%-32.89M
--0
46.17%-32.89M
----
----
-Less:Other special charges
----
----
----
----
----
-67.30%32.89M
--0
-46.17%32.89M
----
----
Other non- operating income (expenses)
-152.43%-727K
189.02%219K
-709.09%-603K
-142.28%-63K
4.15%-277K
-121.15%-288K
-6,050.00%-246K
184.62%99K
344.26%149K
-118.72%-289K
Income before tax
19.19%-526.5M
47.96%-87.15M
26.63%-140M
21.64%-121.84M
-28.88%-177.5M
12.67%-651.5M
-13.47%-167.46M
2.43%-190.82M
29.06%-155.49M
25.01%-137.73M
Income tax
218.68%2.13M
196.74%1.42M
-47.76%233K
-60.08%194K
-76.66%282K
90.06%669K
-517.90%-1.47M
446K
486K
1.21M
Net income
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
28.84%-155.98M
24.35%-138.94M
Net income continuous Operations
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
28.84%-155.98M
24.35%-138.94M
Minority interest income
Net income attributable to the parent company
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
28.84%-155.98M
24.35%-138.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
28.84%-155.98M
24.35%-138.94M
Basic earnings per share
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
30.43%-6.15
1.96%-1.5
23.25%-1.75
46.32%-1.46
38.79%-1.42
Diluted earnings per share
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
30.43%-6.15
1.96%-1.5
23.25%-1.75
46.32%-1.46
38.79%-1.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M13.31%75.42M-62.41%22.66M290.37%22.06M2,519.90%16.32M14.38M
Operating revenue 425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M13.31%75.42M-62.41%22.66M290.37%22.06M2,519.90%16.32M--14.38M
Cost of revenue 938.15%58.51M580.75%19.91M1,522.74%22.41M10,118.29%8.38M526.22%7.81M8.38%5.64M-42.09%2.93M826.85%1.38M82K1.25M
Gross profit 384.45%338.08M540.72%126.47M325.58%87.99M433.19%86.59M181.99%37.04M13.73%69.79M-64.27%19.74M275.84%20.68M2,506.74%16.24M13.13M
Operating expense 28.72%855.2M14.80%210.98M29.64%225.07M25.58%207.03M49.24%212.12M11.17%664.4M27.07%183.79M30.05%173.61M-15.42%164.86M14.08%142.13M
Selling and administrative expenses 80.69%500.82M67.96%141.7M85.76%145.65M76.21%111.37M99.45%102.09M56.79%277.16M103.48%84.37M71.33%78.41M29.07%63.2M26.14%51.19M
-General and administrative expense 80.69%500.82M67.96%141.7M85.76%145.65M76.21%111.37M99.45%102.09M56.79%277.16M103.48%84.37M71.33%78.41M29.07%63.2M26.14%51.19M
Research and development costs -8.48%354.39M-30.32%69.28M-16.58%79.42M-5.90%95.66M20.98%110.03M-7.99%387.24M-3.64%99.42M8.52%95.21M-30.34%101.66M8.25%90.95M
Operating profit 13.03%-517.12M48.48%-84.52M10.37%-137.08M18.96%-120.44M-35.73%-175.08M-10.88%-594.61M-83.50%-164.05M-19.49%-152.94M23.50%-148.62M-3.54%-129M
Net non-operating interest income expense 63.53%-8.65M9.77%-2.85M54.44%-2.32M80.92%-1.34M74.69%-2.14M-84.92%-23.71M-6.11%-3.16M-138.26%-5.09M-91.54%-7.02M-108.86%-8.44M
Non-operating interest income 134.83%20.93M-0.59%4.55M77.61%4.99M319.13%6M5,403.06%5.39M2,032.54%8.91M12,264.86%4.58M1,850.69%2.81M1,276.92%1.43M-26.87%98K
Non-operating interest expense -9.33%29.58M-4.34%7.4M-7.50%7.31M-13.10%7.34M-11.82%7.53M146.40%32.63M156.39%7.74M246.32%7.9M124.26%8.45M104.50%8.54M
Other net income (expense) 97.81%-727K189.02%219K98.16%-603K-142.28%-63K4.15%-277K83.15%-33.18M99.55%-246K49.89%-32.79M100.70%149K99.47%-289K
Special income (charges) --0--0--0--------67.30%-32.89M--046.17%-32.89M--------
-Less:Other special charges ---------------------67.30%32.89M--0-46.17%32.89M--------
Other non- operating income (expenses) -152.43%-727K189.02%219K-709.09%-603K-142.28%-63K4.15%-277K-121.15%-288K-6,050.00%-246K184.62%99K344.26%149K-118.72%-289K
Income before tax 19.19%-526.5M47.96%-87.15M26.63%-140M21.64%-121.84M-28.88%-177.5M12.67%-651.5M-13.47%-167.46M2.43%-190.82M29.06%-155.49M25.01%-137.73M
Income tax 218.68%2.13M196.74%1.42M-47.76%233K-60.08%194K-76.66%282K90.06%669K-517.90%-1.47M446K486K1.21M
Net income 18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M28.84%-155.98M24.35%-138.94M
Net income continuous Operations 18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M28.84%-155.98M24.35%-138.94M
Minority interest income
Net income attributable to the parent company 18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M28.84%-155.98M24.35%-138.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M28.84%-155.98M24.35%-138.94M
Basic earnings per share 27.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.5630.43%-6.151.96%-1.523.25%-1.7546.32%-1.4638.79%-1.42
Diluted earnings per share 27.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.5630.43%-6.151.96%-1.523.25%-1.7546.32%-1.4638.79%-1.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday-1.09%